文献速递临床试验与 GCP真实世界研究与卫生经济

新加坡SingHypertension整群随机试验:管理高血压与多重危险因素以提升心血管健康

Management of hypertension and multiple risk factors to enhance cardiovascular health in Singapore: The SingHypertension cluster randomized trial.
PubMed 文献 · Trials · 2018-03-14

该整群随机试验在新加坡8家综合诊所开展,比较多组分干预与常规照护对未控制高血压成人降压效果及成本效果的影响。干预包括算法驱动的单片复方制剂治疗、动机性访谈、护士电话随访和药物折扣,主要结局为24个月收缩压变化,计划纳入1000名≥40岁患者。

要点

  • 多组分干预含单片复方制剂算法治疗、动机性访谈、护士电话随访及药物折扣。
  • 主要结局为随机化后24个月收缩压较基线的变化。
  • 将计算每避免一个CVD伤残调整生命年和每挽救一个质量调整生命年的增量成本。

核心结论

  • 该试验旨在评估多组分干预降低未控制高血压成人血压的有效性和成本效果。

研究设计与样本

  • 整群随机试验在新加坡8家综合诊所开展,4家实施多组分干预,4家实施常规照护。
  • 计划纳入1000名年龄≥40岁、未控制高血压的个体,收缩压≥140 mmHg或舒张压≥90 mmHg(取三次测量中后两次的平均值)。

关键数值与推荐

  • 主要结局为随机化后24个月随访时收缩压较基线的变化。
  • 将计算多组分干预每避免一个CVD伤残调整生命年的增量成本及每挽救一个质量调整生命年的增量成本。

临床怎么用

  • 若证明有效且成本效果良好,可为在新加坡所有初级保健中心乃至类似卫生保健结构的区域国家推广该方案提供有力证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypertension is a serious public health problem in Singapore and is associated with significant morbidity and mortality from cardiovascular disease (CVD) with considerable implications for health-care resources. The goal of the trial is to compare a multicomponent intervention (MCI) to usual care to evaluate the effectiveness and cost-effectiveness of the MCI for lowering blood pressure (BP) among adults with uncontrolled hypertension in Singapore primary-care clinics. METHODS/DESIGN: The study is a cluster randomized trial in eight polyclinics in Singapore: four deliver a structured MCI and four deliver usual care. The components of the MCI are: (1) an algorithm-driven antihypertensive treatment for all hypertensive individuals using single-pill combination (SPC) and lipid-lowering medication for high-risk hypertensive individuals, (2) a motivational conversation for high-risk hypertensive individuals, (3) telephone-based follow-ups of all hypertensive individuals by polyclinic nurses, and (4) discounts on SPC antihypertensive medications. The trial will be conducted with 1000 individuals aged ≥ 40 years with uncontrolled hypertension (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg, based on the mean of the last two of three measurements) in eight polyclinics in Singapore. The primary outcome is change in systolic BP from baseline to follow-up at 24 months post-randomization. The incremental cost of MCI per CVD disability adjusted life years (DALY) averted and quality adjusted life years (QALY) saved will be computed. DISCUSSION: The demonstration of an effective and cost-effective hypertension control program that is implementable in busy polyclinics would provide compelling evidence for upscaling the program across all primary-care centers in Singapore, and possibly other regional countries with a similar health-care structure. TRIAL REGISTRATION: Clinicaltrials.gov, NCT02972619 . Registered on 23 November 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Jafar TH, Tan NC, Allen JC, et al. Management of hypertension and multiple risk factors to enhance cardiovascular health in Singapore: The SingHypertension cluster randomized trial. Trials. 2018. PMID: 29540213. doi:10.1186/s13063-018-2559-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。